Corporate Governance
Intimation to Stock Exchange
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of the Board meeting dated 25-Oct-24
Intimation of Cessation of Directors of the Company
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Presentation to analysts on Financial Results for the quarter ended 30th June, 2024
Intimation of Cessation of Whole-time Director of the Company
Change in Senior Management Personnel
Intimation of the Board Meeting dated 24-05-2024
Intimation of the Board meeting dated 23-Jul-24
Proceedings of 51st Annual General Meeting of the Company held on 23rd July, 2024
Intimation for Incorporation of Wholly Owned Subsidiary (WOS)
Intimation of Schedule of Investors Meets under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Torrent Pharmaceuticals Limited (Torrent) refutes claims of Shelcal 500 allegedly failing CDSCO quality test – Press Release.
Voting Results and Scrutinizer's Report AGM dated 23-07-2024
Shareholding Pattern Q1
Intimation for Concall with Investors / Analyst Q4_2023-24
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Credit Rating
Intimation for Trading Window Closure_Q1
Change in Senior Management Personnel
Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize its Novel Gastrointestinal Drug in India
Newspaper advertisement regarding Intimation of the 51st AGM of the Company through VC / OAVM facility
Newspaper advertisement in respect of Annual General Meeting and E-Voting Procedure
Intimation regarding Issue of Commercial Papers
Shareholding Pattern Q2
Intimation for Concall with Investors / Analyst Q2_2024-25
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Presentation to analysts on Financial Results for the quarter ended 30th September, 2024
Outcome of Board Meeting Dated 25-Oct-24
Intimation of Credit Rating
Intimation for Trading Window Closure_Q2
Intimation for Concall with Investors / Analyst Q1_2024-25
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Investors Meets under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
